Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
PBLS

Parabilis Medicines (PBLS) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $27.48 -2.2% on the day -13.0% over 12 months 52-week range $25.01 – $41.73

Share price and insider trades

PBLS closeInsider buyInsider sale
2530354045JulAugSepOctBought $233,396 on 2026-06-12 · Alan SebulskyBought $240,162 on 2026-06-15 · Alan SebulskyBought $1,406,632 on 2026-07-22 · Ra Capital Management, L.P.Bought $1,928,032 on 2026-07-21 · Ra Capital Management, L.P.Bought $3,584,887 on 2026-07-20 · Ra Capital Management, L.P.Bought $434,025,000 on 2026-06-11 · Alan Sebulsky, Ra Capital Nexus Fund Iii, L.P., Soleus Capital Group, Llc
Bought, 12 months$441M
Sold, 12 months$0
Insiders buying4
Insiders selling0

Parabilis Medicines insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $441M and 0 sold $0 of PBLS stock on the open market, including a cluster buy that began Jun 11, 2026.

PBLS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $434M bought (8 trades)$434MQ2 2026Q3 2026: $6.9M bought (6 trades)$6.9MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$6.9M6—0
Q2 2026$434M8—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit+$162MOn all tracked purchases +36.7%

Summary

Over the past 12 months, 4 Parabilis Medicines, Inc. insiders reported open-market purchases totaling $441M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Jun 11, 2026, when 3 insiders bought a combined $434M. Among insiders with enough purchase history to measure, Alan Sebulsky (Director) has the highest Insider Score at 93.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 22SEC Ra Capital Management, L.P.Director Buy 98,43326,383,526 held (+0%) $27.13 $2.7M +1.3% 92
Jul 22SEC Ra Capital Management, L.P.Director Buy 47,25026,529,686 held (+0%) $29.77 $1.4M -7.7% 92
Jul 22SEC Ra Capital Management, L.P.Director Buy 37,72326,482,436 held (+0%) $30.00 $1.1M -8.4% 92
Jul 22SEC Ra Capital Management, L.P.Director Buy 32,98726,416,513 held (+0%) $27.72 $914K -0.9% 92
Jul 22SEC Ra Capital Management, L.P.Director Buy 21,69626,438,209 held (+0%) $27.96 $607K -1.7% 92
Jul 22SEC Ra Capital Management, L.P.Director Buy 6,50426,444,713 held (+0%) $29.17 $190K -5.8% 92
Jun 29SEC Soleus Capital Group, Llc10% Owner Buy 375,0001,027,000 held (+58%) $20.00 $7.5M +37.4% —
Jun 29SEC Soleus Capital Group, Llc10% Owner Buy 125,000652,000 held (+24%) $20.00 $2.5M +37.4% —
Jun 16SEC Alan SebulskyDirector Buy 8,43520,935 held (+67%) $27.67 $233K -0.7% 93
Jun 16SEC Alan SebulskyDirector Buy 5,00025,935 held (+24%) $26.00 $130K +5.7% 93
Jun 16SEC Alan SebulskyDirector Buy 4,06530,000 held (+16%) $27.10 $110K +1.4% 93
Jun 15SEC Ra Capital Nexus Fund Iii, L.P.Director Buy 19,728,35326,285,093 held (+301%) $20.00 $395M +37.4% 85
Jun 15SEC Ra Capital Nexus Fund Iii, L.P.Director Buy 1,460,3972,648,278 held (+123%) $20.00 $29.2M +37.4% 85
Jun 15SEC Alan SebulskyDirector Buy 12,500new position $20.00 $250K +37.4% 93

Insiders at Parabilis Medicines, Inc.

InsiderBoughtSoldLast filingScore
Ra Capital Nexus Fund Iii, L.P.Director $424M — Jun 15, 2026 85
Soleus Capital Group, Llc10% Owner $10.0M — Jun 29, 2026 —
Ra Capital Management, L.P.Director $6.9M — Jul 22, 2026 92
Alan SebulskyDirector $724K — Jun 16, 2026 93

PBLS stock: common questions

Are Parabilis Medicines, Inc. insiders buying PBLS stock?

In the past 12 months, 4 insiders reported open-market purchases of PBLS worth $441M. The latest was Director Ra Capital Management, L.P. bought $2.7M of PBLS at $27.13 — first open-market purchase in our records.

Are Parabilis Medicines, Inc. insiders selling PBLS stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PBLS's 52-week range?

Over the past year PBLS has traded between $25.01 and $41.73. It last closed at $27.48 on Oct 9, 2026.